Natural history of gastro-oesophageal reflux disease diagnosed in general practice. Ruigómez, A., García Rodríguez, L. A., Wallander, M., Johansson, S., Graffner, H., & Dent, J. Alimentary Pharmacology & Therapeutics, 20(7):751--760, October, 2004. doi abstract bibtex BACKGROUND: Cross-sectional studies indicate that gastro-oesophageal reflux disease symptoms have a prevalence of 10-20% in Western countries and are associated with obesity, smoking, oesophagitis, chest pain and respiratory disease. AIM: To determine the natural history of gastro-oesophageal reflux disease presenting in primary care in the UK. METHODS: Patients with a first diagnosis of gastro-oesophageal reflux disease during 1996 were identified in the UK General Practice Research Database and compared with age- and sex-matched controls. We investigated the incidence of gastro-oesophageal reflux disease, potential risk factors and comorbidities, and relative risk for subsequent oesophageal complications and mortality. RESULTS: The incidence of a gastro-oesophageal reflux disease diagnosis was 4.5 per 1000 person-years (95% confidence interval: 4.4-4.7). Prior use of non-steroidal anti-inflammatory drugs, smoking, excess body weight and gastrointestinal and cardiac conditions were associated with an increased risk of gastro-oesophageal reflux disease diagnosis. Subjects with gastro-oesophageal reflux disease had an increased risk of respiratory problems, chest pain and angina in the year after diagnosis, and had a relative risk of 11.5 (95% confidence interval: 5.9-22.3) of being diagnosed with an oesophageal complication. There was an increase in mortality in the gastro-oesophageal reflux disease cohort only in the year following the diagnosis. CONCLUSIONS: Gastro-oesophageal reflux disease is a disease associated with a range of potentially serious oesophageal complications and extra-oesophageal diseases.
@article{ruigomez_natural_2004,
title = {Natural history of gastro-oesophageal reflux disease diagnosed in general practice},
volume = {20},
issn = {0269-2813},
doi = {10.1111/j.1365-2036.2004.02169.x},
abstract = {BACKGROUND: Cross-sectional studies indicate that gastro-oesophageal reflux disease symptoms have a prevalence of 10-20\% in Western countries and are associated with obesity, smoking, oesophagitis, chest pain and respiratory disease.
AIM: To determine the natural history of gastro-oesophageal reflux disease presenting in primary care in the UK.
METHODS: Patients with a first diagnosis of gastro-oesophageal reflux disease during 1996 were identified in the UK General Practice Research Database and compared with age- and sex-matched controls. We investigated the incidence of gastro-oesophageal reflux disease, potential risk factors and comorbidities, and relative risk for subsequent oesophageal complications and mortality.
RESULTS: The incidence of a gastro-oesophageal reflux disease diagnosis was 4.5 per 1000 person-years (95\% confidence interval: 4.4-4.7). Prior use of non-steroidal anti-inflammatory drugs, smoking, excess body weight and gastrointestinal and cardiac conditions were associated with an increased risk of gastro-oesophageal reflux disease diagnosis. Subjects with gastro-oesophageal reflux disease had an increased risk of respiratory problems, chest pain and angina in the year after diagnosis, and had a relative risk of 11.5 (95\% confidence interval: 5.9-22.3) of being diagnosed with an oesophageal complication. There was an increase in mortality in the gastro-oesophageal reflux disease cohort only in the year following the diagnosis.
CONCLUSIONS: Gastro-oesophageal reflux disease is a disease associated with a range of potentially serious oesophageal complications and extra-oesophageal diseases.},
language = {eng},
number = {7},
journal = {Alimentary Pharmacology \& Therapeutics},
author = {Ruigómez, A. and García Rodríguez, L. A. and Wallander, M.-A. and Johansson, S. and Graffner, H. and Dent, J.},
month = oct,
year = {2004},
pmid = {15379835},
keywords = {Adolescent, Adult, Aged, Anti-Inflammatory Agents, Non-Steroidal, Antirheumatic Agents, Child, Child, Preschool, Cohort Studies, Family Practice, Female, Gastroesophageal Reflux, Great Britain, Humans, Infant, Male, Middle Aged, Nitrates, Patient Acceptance of Health Care, Risk Factors, Steroids},
pages = {751--760}
}
Downloads: 0
{"_id":"9Qzwchs8Y5ymuxdb9","bibbaseid":"ruigmez-garcarodrguez-wallander-johansson-graffner-dent-naturalhistoryofgastrooesophagealrefluxdiseasediagnosedingeneralpractice-2004","downloads":0,"creationDate":"2017-08-15T09:38:11.049Z","title":"Natural history of gastro-oesophageal reflux disease diagnosed in general practice","author_short":["Ruigómez, A.","García Rodríguez, L. A.","Wallander, M.","Johansson, S.","Graffner, H.","Dent, J."],"year":2004,"bibtype":"article","biburl":"http://bibbase.org/zotero/veegee78","bibdata":{"bibtype":"article","type":"article","title":"Natural history of gastro-oesophageal reflux disease diagnosed in general practice","volume":"20","issn":"0269-2813","doi":"10.1111/j.1365-2036.2004.02169.x","abstract":"BACKGROUND: Cross-sectional studies indicate that gastro-oesophageal reflux disease symptoms have a prevalence of 10-20% in Western countries and are associated with obesity, smoking, oesophagitis, chest pain and respiratory disease. AIM: To determine the natural history of gastro-oesophageal reflux disease presenting in primary care in the UK. METHODS: Patients with a first diagnosis of gastro-oesophageal reflux disease during 1996 were identified in the UK General Practice Research Database and compared with age- and sex-matched controls. We investigated the incidence of gastro-oesophageal reflux disease, potential risk factors and comorbidities, and relative risk for subsequent oesophageal complications and mortality. RESULTS: The incidence of a gastro-oesophageal reflux disease diagnosis was 4.5 per 1000 person-years (95% confidence interval: 4.4-4.7). Prior use of non-steroidal anti-inflammatory drugs, smoking, excess body weight and gastrointestinal and cardiac conditions were associated with an increased risk of gastro-oesophageal reflux disease diagnosis. Subjects with gastro-oesophageal reflux disease had an increased risk of respiratory problems, chest pain and angina in the year after diagnosis, and had a relative risk of 11.5 (95% confidence interval: 5.9-22.3) of being diagnosed with an oesophageal complication. There was an increase in mortality in the gastro-oesophageal reflux disease cohort only in the year following the diagnosis. CONCLUSIONS: Gastro-oesophageal reflux disease is a disease associated with a range of potentially serious oesophageal complications and extra-oesophageal diseases.","language":"eng","number":"7","journal":"Alimentary Pharmacology & Therapeutics","author":[{"propositions":[],"lastnames":["Ruigómez"],"firstnames":["A."],"suffixes":[]},{"propositions":[],"lastnames":["García","Rodríguez"],"firstnames":["L.","A."],"suffixes":[]},{"propositions":[],"lastnames":["Wallander"],"firstnames":["M.-A."],"suffixes":[]},{"propositions":[],"lastnames":["Johansson"],"firstnames":["S."],"suffixes":[]},{"propositions":[],"lastnames":["Graffner"],"firstnames":["H."],"suffixes":[]},{"propositions":[],"lastnames":["Dent"],"firstnames":["J."],"suffixes":[]}],"month":"October","year":"2004","pmid":"15379835","keywords":"Adolescent, Adult, Aged, Anti-Inflammatory Agents, Non-Steroidal, Antirheumatic Agents, Child, Child, Preschool, Cohort Studies, Family Practice, Female, Gastroesophageal Reflux, Great Britain, Humans, Infant, Male, Middle Aged, Nitrates, Patient Acceptance of Health Care, Risk Factors, Steroids","pages":"751--760","bibtex":"@article{ruigomez_natural_2004,\n\ttitle = {Natural history of gastro-oesophageal reflux disease diagnosed in general practice},\n\tvolume = {20},\n\tissn = {0269-2813},\n\tdoi = {10.1111/j.1365-2036.2004.02169.x},\n\tabstract = {BACKGROUND: Cross-sectional studies indicate that gastro-oesophageal reflux disease symptoms have a prevalence of 10-20\\% in Western countries and are associated with obesity, smoking, oesophagitis, chest pain and respiratory disease.\nAIM: To determine the natural history of gastro-oesophageal reflux disease presenting in primary care in the UK.\nMETHODS: Patients with a first diagnosis of gastro-oesophageal reflux disease during 1996 were identified in the UK General Practice Research Database and compared with age- and sex-matched controls. We investigated the incidence of gastro-oesophageal reflux disease, potential risk factors and comorbidities, and relative risk for subsequent oesophageal complications and mortality.\nRESULTS: The incidence of a gastro-oesophageal reflux disease diagnosis was 4.5 per 1000 person-years (95\\% confidence interval: 4.4-4.7). Prior use of non-steroidal anti-inflammatory drugs, smoking, excess body weight and gastrointestinal and cardiac conditions were associated with an increased risk of gastro-oesophageal reflux disease diagnosis. Subjects with gastro-oesophageal reflux disease had an increased risk of respiratory problems, chest pain and angina in the year after diagnosis, and had a relative risk of 11.5 (95\\% confidence interval: 5.9-22.3) of being diagnosed with an oesophageal complication. There was an increase in mortality in the gastro-oesophageal reflux disease cohort only in the year following the diagnosis.\nCONCLUSIONS: Gastro-oesophageal reflux disease is a disease associated with a range of potentially serious oesophageal complications and extra-oesophageal diseases.},\n\tlanguage = {eng},\n\tnumber = {7},\n\tjournal = {Alimentary Pharmacology \\& Therapeutics},\n\tauthor = {Ruigómez, A. and García Rodríguez, L. A. and Wallander, M.-A. and Johansson, S. and Graffner, H. and Dent, J.},\n\tmonth = oct,\n\tyear = {2004},\n\tpmid = {15379835},\n\tkeywords = {Adolescent, Adult, Aged, Anti-Inflammatory Agents, Non-Steroidal, Antirheumatic Agents, Child, Child, Preschool, Cohort Studies, Family Practice, Female, Gastroesophageal Reflux, Great Britain, Humans, Infant, Male, Middle Aged, Nitrates, Patient Acceptance of Health Care, Risk Factors, Steroids},\n\tpages = {751--760}\n}\n\n","author_short":["Ruigómez, A.","García Rodríguez, L. A.","Wallander, M.","Johansson, S.","Graffner, H.","Dent, J."],"key":"ruigomez_natural_2004","id":"ruigomez_natural_2004","bibbaseid":"ruigmez-garcarodrguez-wallander-johansson-graffner-dent-naturalhistoryofgastrooesophagealrefluxdiseasediagnosedingeneralpractice-2004","role":"author","urls":{},"keyword":["Adolescent","Adult","Aged","Anti-Inflammatory Agents","Non-Steroidal","Antirheumatic Agents","Child","Child","Preschool","Cohort Studies","Family Practice","Female","Gastroesophageal Reflux","Great Britain","Humans","Infant","Male","Middle Aged","Nitrates","Patient Acceptance of Health Care","Risk Factors","Steroids"],"downloads":0},"search_terms":["natural","history","gastro","oesophageal","reflux","disease","diagnosed","general","practice","ruigómez","garcía rodríguez","wallander","johansson","graffner","dent"],"keywords":["adolescent","adult","aged","anti-inflammatory agents","non-steroidal","antirheumatic agents","child","child","preschool","cohort studies","family practice","female","gastroesophageal reflux","great britain","humans","infant","male","middle aged","nitrates","patient acceptance of health care","risk factors","steroids"],"authorIDs":[],"dataSources":["FmCWXwJibZiWNzpdc"]}